
Identification of two novel insertion abnormal transcripts in two Chinese families affected with Dystrophinopathy
Author(s) -
Xu Ying,
Song Tingting,
Li Yu,
Guo Fenfen,
Jin Xin,
Cheng Lu,
Zheng Jiao,
Li Chunyan,
Zhang Yingqi,
Chen Biliang,
Zhang Jianfang
Publication year - 2020
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.23142
Subject(s) - genetics , exon , multiplex ligation dependent probe amplification , biology , gene , intron , stop codon , duchenne muscular dystrophy , mutation , dystrophin , microbiology and biotechnology
Background Duchenne muscular dystrophy (DMD) is an X‐linked recessive inheritance muscle dystrophy disease, associated with pathogenic variants in the DMD gene. MLPA, DHPLC and DMD sequence studies fail to found the causative alteration in two cases. This study intends to evaluate the disease‐causing mutations and explains the correlation genotype‐phenotype. Methods The mRNA analysis and Long‐range PCR with sequencing were used for molecular diagnosis. Results In case one, an insertion of 78 nucleotides between exons 40 and 41 (r.5739_5740insMN602429:r415_492) was identified in case one. The insertion sequences were highly homologous to the intron 40 ( NG_012232.1 :g.1001760_g.1001837). Long‐range PCR with sequencing analysis showed that a novel deep intronic DMD mutation ( NG_012232.1 :g.1001838A>G) was identified, generating a premature stop codon and terminating protein translation. The likely pathogenic mutation was detected in fetal sample. In case two, an insertion of 74 nucleotides which located inside the consensus sequence AG/GT was detected between exons 2 and 3 (r.93_94insMN584887:r61_134), which resulted in a premature stop codon. The insertion sequences were traceable in the intron 2 of DMD gene ( NG_012232.1 :g.415926_g.415999). We did not perform prenatal DMD gene diagnosis for case two due to lack of sufficient genetic information. Conclusion These findings clarify importance of proceeding to the mRNA analysis when no causative mutations were found neither by MLPA/DHPLC nor gene sequencing so as to reach the molecular confirmation of DMD and carry out an accurate genetic assessment/ carrier status testing.